An important indicator of supply and demand uncertainty on electricity markets is risk premium (RP), an integral part of electricity price. The level of RP is describing the risk the market actors expect in the future due to the market uncertainties. With the electricity market price behavior rapidly changing, the rising market supply uncertainty is increasing the volatility of RP. To better understand this behavior, power market participants need new models that will efficiently use the information available in the processes driving the electricity price and RP and to explain the influence of RES uncertainties on the future RP and electricity prices. A decade ago, researchers investigating RP focused primarily on the uncertainties arising from consumption forecast and generation outages. RES share in generation mix was small and its influence on uncertainty was negligible, leading to much lower volatilities of RP than today. With the increasing influence of RES, typically exhibiting variability on a sub-hourly level, traditional models using daily electricity price to calculate RP were becoming inadequate. In this dynamic period of electricity market transformation, this paper highlights the importance of RP signals to market actors. A stochastic method for RP calculation is discussed with the associated RP model, driven by the intraday dynamics. An example of the RP signal is presented on historical price data from the German electricity market, highlighting uncertainty pattern developed over the years. With such an approach, the market actors can adjust their trading strategies thus mitigating their market risk exposure.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.